Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Theravance Biopharma, Inc. - Ordinary Shares
(NQ:
TBPH
)
17.39
-0.56 (-3.12%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Theravance Biopharma, Inc. - Ordinary Shares
< Previous
1
2
3
4
5
6
Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021
↗
November 05, 2021
Upgrades For IGM Biosciences Inc (NASDAQ:
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Jobs Report
↗
November 05, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the S&P 500 and Nasdaq surged to record highs in the previous session. Investors are awaiting...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 04, 2021
Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million...
Via
Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
↗
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Theravance Biopharma, inc (TBPH) Q3 2021 Earnings Call Transcript
↗
November 04, 2021
TBPH earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For November 3, 2021
↗
November 03, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....
Via
Benzinga
More Chinese Trouble
↗
October 14, 2021
A day after the consumer price rise there was another price rise for producer markets.
Via
Talk Markets
A Bit Of A Recovery
↗
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
China's Rescue Of Evergrand
↗
September 23, 2021
The number of jobless last week was higher than the forecast, at 351,000 vs 320,000. The recovery is lagging.
Via
Talk Markets
Analyst Ratings For Theravance Biopharma
↗
September 16, 2021
Analysts have provided the following ratings for Theravance Biopharma (NASDAQ:T...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
↗
September 16, 2021
Barclays boosted Adobe Inc. (NASDAQ:ADBE) price t...
Via
Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
↗
September 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
53 Biggest Movers From Yesterday
↗
September 16, 2021
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...
Via
Benzinga
Topics
Initial Public Offering
Why Theravance Biopharma Stock Dived 16% Today
↗
September 15, 2021
The biotech is not enjoying a winning streak with its pipeline drugs.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares...
Via
Benzinga
Why Are Theravance Bio Shares Plummeting Premarket Today?
↗
September 15, 2021
Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
↗
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
↗
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
August 27, 2021
Before 10 a.m. ET on Friday, 29 stocks hit new 52-week lows. Significant Points: Campbell Soup (NYSE:CPB) was the biggest company by market cap to set a new 52-week low....
Via
Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
↗
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
↗
August 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2021
↗
August 25, 2021
Upgrades For Kite Realty Group Trust (NYSE:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
August 25, 2021
On Wednesday morning, 17 companies hit new 52-week lows. Things to Consider: The largest company by market cap to set a new 52-week low was Campbell Soup (NYSE:CPB...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
↗
August 25, 2021
Wells Fargo raised the price target for Urban Outfitters, Inc. (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
↗
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Here's Why Theravance Biopharma Stock Is Tanking Today
↗
August 24, 2021
The company's second clinical-trial flop in as many months isn't sitting well with investors.
Via
The Motley Fool
Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings
↗
August 24, 2021
Toward the end of trading Tuesday, the Dow traded up 0.26% to 35,427.95 while the NASDAQ rose 0.50% to 15,018.26. The S&P also rose, gaining 0.25% to 4,490.82. The U.S. has...
Via
Benzinga
Topics
Stocks
60 Biggest Movers From Yesterday
↗
August 25, 2021
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...
Via
Benzinga
Vaccine Optimism Pushes S&P 500, Nasdaq to Fresh Intraday Highs
↗
August 24, 2021
This week is so far proving to be much better than the last one, as the three major indexes look to extend yesterday's gains.
Via
Talk Markets
Topics
Stocks
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.